[Use of vindesine in lymphangitic-type cutaneous recurrence of breast cancer].
D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D008205:Lymphangitis / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000556:secondary; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014751:Vindesine
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D000970:Antineoplastic Agents; D014747:Vinblastine; D014751:Vindesine
Utilisation de la vindésine dans les récidives cutanées à forme lymphangitique des cancers mammaires.